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Is survivor guilt from COVID-19 an enigma? 
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Since the beginning of the Covid-19 pandemic, the UK government has prioritised 
research into effective treatments as part of the Coronavirus Action Plan. As two 
research nurses, one normally working in Oncology and the second a senior nurse 
manager with Cardiology research experience, both authors responded to the crisis 
by contributing to the set up and delivery of Covid-19 studies within our Trust. Covid-
19 studies were opened in record time to investigate various treatments that experts 
believed may be effective in treating patients most severely affected.  
 
As part of one trial, six patients were followed up (after discharge) by telephone to 
identify continuing symptoms. During these follow ups all patients reported an 
improvement in their Covid-19 symptoms, although some had on-going respiratory 
problems. 
 
Patients also reported feelings of disbelief in their recovery. Anecdotally, some 
patients expressed the belief that being part of the clinical trial had saved their life. 
One patient expressed gratitude for being approached for the trial and strongly 
believed she would not have survived otherwise. Of the five patients (one died) 
followed-up, four questioned why they had survived when so many had died. They 
also experienced levels of anxiety following discharge, with some reporting being too 
anxious to leave their house, meet with other people or attend hospital. Although this 
article involves only a small number of patients and doesn’t describe a robust 
research methodology, the experiences of these patients are worthy of sharing 
anecdotally to prompt discussion. It is possible that these patients are experiencing a 
form of anxiety, such as survivor guilt.  
 
Survivor guilt is a well-documented phenomenon in trauma and natural disasters. 
First identified in the 1960s, it is a significant symptom of post-traumatic stress 
disorder (PTSD) and is defined as a mental health condition occurring when a 
person believes they have done something wrong by surviving a traumatic event 
when others did not.  
 
The significance of survivor’s guilt in context of a pandemic is underreported. Within 
the context of Covid-19 with significant death rates worldwide, one might consider 
that reports of survivor guilt are not surprising. However, the belief of patients that 
being part of a Clinical Trial has playing a significant role in their survival is an 
interesting concept and is new to the authors. As experienced research nurses 
working in cancer research and acute cardiology, where patients receive life-saving 
and life extending experimental Trial therapies and drugs, one might expect to 
receive similar feedback yet this has not been the case.  
 
It does raise the question of potential longer term mental health consequences and 
whether steps are required to routinely asses Covid-19 patients for survivor guilt, 
PTSD and other mental health issues post discharge. Literature on disaster mental 
health has shown that approximately one third of studies noted severe effects on the 
population’s mental status, high incidence rates of PTSD, major depressive, and 
generalized anxiety disorders. Studies following the SARS pandemic of 2002 
showed that stress, anxiety and stigmatisation were commonplace among people 
surviving the infection. 
 
We still know very little about the short and longer term psychological impact of 
Covid-19 on patients. It is known that nearly one-quarter of intensive care unit 
survivors develop PTSD1, with the amount of sedation received during ventilation 
being an identified risk factor. Medics have been very hesitant to intubate and 
ventilate Covid-19 patients due to poorer outcomes, which introduces the question 
whether sedation plays a part in PTSD or survivor guilt in Covid-19 patients?  
 
The impact of Covid-19 on mental health is unknown; numerous studies are 
underway investigating this further. However, research is needed to specifically 
understand the extent of possible survivor guilt in patients who have recovered and 
how nurses can best support patients. Further research may help to identify 
populations at higher risk of developing mental health problems during a pandemic, 
which may enable the setup of a response framework prior to the onset of similar 
future crises. 
 
In the forthcoming months, the nursing workforce is likely to come across instances 
of survivor guilt. Understanding the signs and symptoms2 is an important starting 
point to allow nurses to better support and sign post patients to gaining further help. 
As nurses, we aim to take a holistic approach when delivering care, ensuring that 
rather than treating only physical symptoms, we also attend to the psychological, 
spiritual and social needs of our patients. However, most of our follow-up encounters 
with trial patients are brief and usually focus on any lingering problems from the trial 
medication or intervention. Nevertheless, in nursing it is important to make every 
contact count (MECC) and therefore the trial follow up is a key opportunity to provide 
holistic care by assessing and delivering psychological support to Covid-19 patients 
during recovery who report feelings of survivor guilt.  
 
 
 
1 https://www.hopkinsmedicine.org/news/media/releases/ptsd_common_in_icu_survivors 
2 https://www.psychologytoday.com/gb/blog/the-empowerment-diary/201801/what-everybody-should-
know-about-survivors-guilt 
